Literature DB >> 23516775

Evaluation and treatment of esophageal varices in the cirrhotic patient.

Eyal Ashkenazi1, Yulia Kovalev, Eli Zuckerman.   

Abstract

Portal hypertension is the leading cause of morbidity and mortality in liver cirrhosis. Complications of portal hypertension in cirrhotic patients include esophageal and gastric varices, portal hypertensive gastropathy, ascites, hepatorenal syndrome, hepatopulmonary syndrome and portopulmonary hypertension. The hepatic venous pressure gradient should be at least 10 mmHg for esophageal varices to appear, and more than 12 mmHg for acute esophageal variceal bleeding. This article reviews the pathophysiology responsible for portal hypertension and its complications, and the treatments used for esophageal varices in the setting of primary and secondary prophylaxis and during active bleeding.

Entities:  

Mesh:

Year:  2013        PMID: 23516775

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


  6 in total

1.  Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.

Authors:  Yoshiyuki Sakai; Yoshinori Iwata; Hirayuki Enomoto; Masaki Saito; Kazunori Yoh; Akio Ishii; Tomoyuki Takashima; Nobuhiro Aizawa; Naoto Ikeda; Hironori Tanaka; Hiroko Iijima; Shuhei Nishiguchi
Journal:  J Gastroenterol       Date:  2014-03-17       Impact factor: 7.527

2.  Platelet count can predict the grade of esophageal varices in cirrhotic patients: a cross-sectional study.

Authors:  Anum Afsar; Muhammad Nadeem; Syed Asim Ali Shah; Huma Hussain; Aysha Rani; Sadaf Ghaffar
Journal:  F1000Res       Date:  2021-02-11

3.  Comparative study for predictability of type 1 gastric variceal rebleeding after endoscopic variceal ligation: High-frequency intraluminal ultrasound study.

Authors:  Jeong Hwan Kim; Won Hyeok Choe; Sun-Young Lee; So Young Kwon; In-Kyung Sung; Hyung Seok Park
Journal:  World J Clin Cases       Date:  2021-12-06       Impact factor: 1.337

4.  Additional Benefits Conferred by Endoscopic Sclerotherapy to Liver Cirrhosis Patients Receiving Endoscopic Variceal Ligation.

Authors:  Xuni He; Hanqing Chen; Mingming Zhang; Jiemin Hong; Peina Shi
Journal:  Evid Based Complement Alternat Med       Date:  2021-10-18       Impact factor: 2.629

5.  Assessment of Non-invasive Markers for the Prediction of Esophageal Variceal Hemorrhage.

Authors:  Shasha Li; Peng Huang; Andre J Jeyarajan; Chao Ma; Ke Zhu; Chuanlong Zhu; Ning Jiang; Ming Li; Tuo Shao; Mingfeng Han; Lin Tan; Wenyu Lin
Journal:  Front Med (Lausanne)       Date:  2021-12-01

6.  Fatal complications after an interrupted gastric bypass operation in a patient with non-alcoholic fatty liver disease and massive obesity: a case report.

Authors:  Pirjo Käkelä; Tuomo Rantanen; Hannu Paajanen; Kirsi A Virtanen
Journal:  J Surg Case Rep       Date:  2021-06-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.